Not Yet RecruitingNot Applicable

SPARK-CGM Implementation

United States20,000 participantsStarted 2026-05

Plain-language summary

Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in primary care settings, where most people receive their diabetes care. The investigators aim to make CGM more accessible and equitably prescribed in primary care practices. The study team will support primary care to increase CGM use with a program called SPARK-CGM (Supporting Primary Care Adoption, Resources, and Knowledge for CGM) across a large network of primary care clinics at Montefiore Medical Center. This program will provide primary care providers (PCPs) with education, tools, and support to incorporate CGM into their routine care for people with diabetes. Investigators plan to test SPARK-CGM to evaluate whether it increases CGM prescriptions who are eligible to receive this technology.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Clinic level: * All adult Montefiore primary care sites * Clinician and clinic staff will be eligible if they provide direct patient care or are involved in CGM prescribing, authorization, onboarding, or education at participating primary care clinics. Eligible clinicians include physicians, nurse practitioners, physician assistants, and clinicians in training. Eligible clinic staff may include nurses, medical assistants, and other relevant administrative staff Patient level: * Age 18 years or older * Receive primary care at participating sites * Diagnosis of any diabetes mellitus * Treated with insulin therapy Exclusion Criteria: Clinic level: \- Sites participating in pilot phase of CGM initiative Patient level: \- Existing CGM prescription within 24 months before the study start

What they're measuring

Time to first CGM prescription by primary care provider

Timeframe: Up to 18 months following initiation of intervention

Trial details

NCT IDNCT07548372

SponsorMontefiore Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-05

Contact for this trial

Rosina Antwi

646-515-8399 rosina.antwi@einsteinmed.edu